Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Lifecore Biomedical, Inc. before investing.

In this article, we go over a few key elements for understanding Lifecore Biomedical, Inc.’s stock price such as:

• Lifecore Biomedical, Inc.’s current stock price and volume
• Why Lifecore Biomedical, Inc.’s stock price changed recently
• Upgrades and downgrades for LFCR from analysts
• LFCR’s stock price momentum as measured by its relative strength

About Lifecore Biomedical, Inc. (LFCR)

Before we jump into Lifecore Biomedical, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacture of hyaluronate acid in bulk form; and formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures. It also provides product development services include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and production of materials for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Want to learn more about Lifecore Biomedical, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Lifecore Biomedical, Inc..

Lifecore Biomedical, Inc.’s Stock Price as of Market Close

As of January 16, 2026, 4:00 PM, CST, Lifecore Biomedical, Inc.’s stock price was $8.220.

Lifecore Biomedical, Inc. is up 1.48% from its previous closing price of $8.100.

During the last market session, Lifecore Biomedical, Inc.’s stock traded between $8.080 and $8.400. Currently, there are approximately 37.40 million shares outstanding for Lifecore Biomedical, Inc..

Lifecore Biomedical, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Lifecore Biomedical, Inc. Stock Price History

Lifecore Biomedical, Inc.’s (LFCR) price is currently up 0.49% so far this month.

During the month of January, Lifecore Biomedical, Inc.’s stock price has reached a high of $8.430 and a low of $7.320.

Over the last year, Lifecore Biomedical, Inc. has hit prices as high as $8.850 and as low as $4.760. Year to date, Lifecore Biomedical, Inc.’s stock is up 0.49%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Lifecore Biomedical, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of January 16, 2026,, no analysts have changed their rating of Lifecore Biomedical, Inc.’s stock over the last month.

Additionally, you'll want to evaluate Lifecore Biomedical, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Lifecore Biomedical, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Lifecore Biomedical, Inc. (LFCR) by visiting AAII Stock Evaluator.

Relative Price Strength of Lifecore Biomedical, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of January 16, 2026, Lifecore Biomedical, Inc. has a weighted four-quarter relative price strength of 7.02%, which translates to a Momentum Score of 73 and is considered to be Strong.

Want to learn more about how Lifecore Biomedical, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Lifecore Biomedical, Inc. Stock Price: Bottom Line

As of January 16, 2026, Lifecore Biomedical, Inc.’s stock price is $8.220, which is up 1.48% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Lifecore Biomedical, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.